These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30663903)

  • 1. The value of KRAS gene status in predicting local tumor progression of colorectal liver metastases following radiofrequency ablation.
    Jiang BB; Yan K; Zhang ZY; Yang W; Wu W; Yin SS; Chen MH
    Int J Hyperthermia; 2019 Jan; 36(1):211-219. PubMed ID: 30663903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
    Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation.
    Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W
    Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.
    Shady W; Petre EN; Vakiani E; Ziv E; Gonen M; Brown KT; Kemeny NE; Solomon SB; Solit DB; Sofocleous CT
    Oncotarget; 2017 Sep; 8(39):66117-66127. PubMed ID: 29029497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer.
    Bai XM; Yang W; Zhang ZY; Jiang AN; Wu W; Lee JC; Chen MH; Yan K
    Int J Hyperthermia; 2019 Jan; 35(1):183-193. PubMed ID: 30200791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.
    Sotirchos VS; Petrovic LM; Gönen M; Klimstra DS; Do RK; Petre EN; Garcia AR; Barlas A; Erinjeri JP; Brown KT; Covey AM; Alago W; Brody LA; DeMatteo RP; Kemeny NE; Solomon SB; Manova-Todorova KO; Sofocleous CT
    Radiology; 2016 Sep; 280(3):949-59. PubMed ID: 27010254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-centre retrospective review of risk factors for local tumour progression and complications in radiofrequency ablation of 555 hepatic lesions.
    Chua JME; Lam YMP; Tan BS; Tay KH; Gogna A; Irani FG; Lo HGR; Too CW
    Singapore Med J; 2019 Apr; 60(4):188-192. PubMed ID: 31069400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes and prognostic factors of cone-beam CT-guided radiofrequency ablation for pulmonary metastases in colorectal cancer patients.
    Hong HP; Kim HO; Koo DH; Lee YG; Kim MS; Ham SY; Kang DY; Oh TY; Lee H; Jung KU; Kim H
    Asia Pac J Clin Oncol; 2023 Oct; 19(5):e215-e222. PubMed ID: 35822242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local recurrence rate in patients with colorectal cancer liver metastasis after wedge resection or percutaneous radiofrequency ablation.
    Vietti Violi N; Duran R; Demartines N; Sempoux C; Guiu B; Bize PE; Sala N; Halkic N; Knebel JF; Denys A
    Int J Hyperthermia; 2018 Nov; 34(7):1020-1028. PubMed ID: 29506424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.
    Wang X; Sofocleous CT; Erinjeri JP; Petre EN; Gonen M; Do KG; Brown KT; Covey AM; Brody LA; Alago W; Thornton RH; Kemeny NE; Solomon SB
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):166-75. PubMed ID: 22535243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
    Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT
    Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.
    Sofocleous CT; Petre EN; Gonen M; Brown KT; Solomon SB; Covey AM; Alago W; Brody LA; Thornton RH; D'Angelica M; Fong Y; Kemeny NE
    J Vasc Interv Radiol; 2011 Jun; 22(6):755-61. PubMed ID: 21514841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hepatocellular carcinoma in the caudate lobe: US-guided percutaneous radiofrequency ablation combined with ethanol ablation.
    Liu B; Long J; Wang W; Huang G; Jiang C; Zhang X; Liu M; Liang P; Yu J; Xie X; Kuang M
    Clin Radiol; 2018 Jul; 73(7):647-656. PubMed ID: 29627066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience.
    Huang J; Xie X; Lin J; Wang W; Zhang X; Liu M; Li X; Huang G; Liu B; Xie X
    Cancer Imaging; 2019 Jun; 19(1):44. PubMed ID: 31242934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive nomograms of repeat intrahepatic recurrence and overall survival after radiofrequency ablation of recurrent colorectal liver metastases.
    Wang JC; Jiang BB; Zhang ZY; Liu YH; Shao LJ; Wang S; Yang W; Wu W; Yan K
    Int J Hyperthermia; 2024; 41(1):2323152. PubMed ID: 38465646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience.
    Wang Y; Zhang GY; Xu LC; He XH; Huang HZ; Li GD; Wang YH; Wang GZ; Li WT
    Technol Cancer Res Treat; 2020; 19():1533033820963662. PubMed ID: 33034276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation for colorectal cancer liver metastases initially greater than 25 mm but downsized by neo-adjuvant chemotherapy is associated with increased rate of local tumor progression.
    Benhaim L; El Hajjam M; Malafosse R; Sellier J; Julie C; Beauchet A; Nordlinger B; Peschaud F
    HPB (Oxford); 2018 Jan; 20(1):76-82. PubMed ID: 29029986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.
    Lahti SJ; Xing M; Zhang D; Lee JJ; Magnetta MJ; Kim HS
    J Vasc Interv Radiol; 2015 Aug; 26(8):1102-11. PubMed ID: 26210240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-guided percutaneous radiofrequency ablation in treatment of neuroendocrine tumor liver metastases：a single-center experience.
    Huang J; Liu B; Lin M; Zhang X; Zheng Y; Xie X; Xu M; Xie X
    Int J Hyperthermia; 2022; 39(1):497-503. PubMed ID: 35285400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.